Technologies
Aprea Therapeutics Inc (NASDAQ: APRE): Would You Buy Today?
In today’s recent session, 1.07 million shares of the Aprea Therapeutics Inc (NASDAQ:APRE) have been traded, and its beta is 1.06. Most recently the company’s
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
